BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Antimicrobial Properties of a Potential Probiotic Lactobacillus from Thai Newborn Feces. ✅
Journal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai ) Vol: 98 Suppl 9 Issue Pages: S116-22 Pub: 2015 Oct Epub: Authors Chimchang J , Theparee T , Ladda B , Tanasupawat S , Wongsatayanon BT , Taweechotipatr M , |
|
|
Coexpression and secretion of endoglucanase and phytase genes in Lactobacillus reuteri. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 15 Issue 7 Pages: 12842-60 Pub: 2014 Jul 21 Epub: 2014 Jul 21 Authors Wang L , Yang Y , Cai B , Cao P , Yang M , Chen Y , |
|
|
<i>Lactobacillus reuteri</i> DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. ✅
Go to Publication ✅
American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2019 Sep 4 Epub: 2019 Sep 4 Authors Liu Y , Tian X , He B , Hoang TK , Taylor CM , Blanchard E , Freeborn J , Park S , Luo M , Couturier J , Tran DQ , Roos S , Wu G , Rhoads JM , |
|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Lactobacillus reuteri inhibits Staphylococcus aureus-induced mastitis by regulating oxytocin releasing and gut microbiota in mice. ✅
Go to Publication ✅
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 38 Issue 2 Pages: e23383 Pub: 2024 Jan 31 Epub: Authors He Z , Li W , Yuan W , He Y , Xu J , Yuan C , Zhao C , Zhang N , Fu Y , Hu X , |
|
|
Effects of drinking water supplementation with Lactobacillus reuteri, and a mixture of reuterin and microcin J25 on the growth performance, caecal microbiota and selected metabolites of broiler chickens. ✅
Go to Publication ✅
Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 13 Issue 1 Pages: 34 Pub: 2022 Mar 5 Epub: 2022 Mar 5 Authors Zhang L , Ben Said L , Hervé N , Zirah S , Diarra MS , Fliss I , |
|
|
[Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice]. ✅
Go to Publication ✅
Sheng wu gong cheng xue bao = Chinese journal of biotechnology (Sheng Wu Gong Cheng Xue Bao ) Vol: 36 Issue 9 Pages: 1887-1898 Pub: 2020 Sep 25 Epub: Authors Liu M , Hu R , Guo Y , Sun W , Li J , Fan M , Wang Y , Du H , Tang Z , Chai C , |
|
|
Galactooligosaccharides and Limosilactobacillus reuteri synergistically alleviate gut inflammation and barrier dysfunction by enriching Bacteroides acidifaciens for pentadecanoic acid biosynthesis. ✅
Go to Publication ✅
Nature communications (Nat Commun ) Vol: 15 Issue 1 Pages: 9291 Pub: 2024 Oct 28 Epub: 2024 Oct 28 Authors Wu Y , Zhang X , Liu X , Zhao Z , Tao S , Xu Q , Zhao J , Dai Z , Zhang G , Han D , Wang J , |
|
|
Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 314 Issue Pages: 121309 Pub: 2023 Feb 1 Epub: 2022 Dec 20 Authors Lin C , Zheng Y , Lu J , Zhang H , Wang G , Chen W , |
|
|
Exopolysaccharides from camel milk-derived Limosilactobacillus reuteri C66: Structural characterization, bioactive and rheological properties for food applications. ✅
Go to Publication ✅
Food chemistry: X (Food Chem X ) Vol: 25 Issue Pages: 102164 Pub: 2025 Jan Epub: 2025 Jan 27 Authors Kober AKMH , Abdin M , Subhash A , Liu SQ , Dertli E , Abu-Jdayil B , Show PL , Ayyash M , |
|
|
Limosilactobacillus reuteri NCU-37 alleviates leuprorelin-induced perimenopausal syndrome in infertile women by modulating the gut microbiota: a randomized controlled trial. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2025 Dec 16 Epub: 2025 Dec 16 Authors Wu X , Chen W , Yong Q , Zeng Q , You J , Zeng K , Li T , Wei J , Xie Y , Xu T , Chen T , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
